Epitel is a neurotechnology company developing wearable EEG solutions designed for extended, continuous brain monitoring in real-world environments. The company focuses on overcoming the limitations of traditional short-duration EEG by enabling long-term data collection without restricting patient mobility.

Its core product, REMI, is a wearable EEG system that combines a lightweight electrode array with cloud-based analytics to support continuous recording and remote review. The system is designed for ease of application and sustained use, supporting high-quality EEG acquisition over days rather than hours.

Epitel’s technology is intended for clinical and research use in epilepsy monitoring, seizure detection, and broader neurological assessment. The company positions its platform as a diagnostic and monitoring infrastructure that expands access to prolonged EEG outside specialized inpatient settings.